James Investment Research’s iShares Biotechnology ETF IBB Stock Holding History

James Investment Research’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-190	Closed	-$25K	–	388
2023 Q1	$25K	Hold	190	–	–	﹤0.01%	423
2022 Q4	$25K	Hold	190	–	–	﹤0.01%	431
2022 Q3	$22K	Hold	190	–	–	﹤0.01%	432
2022 Q2	$22K	Hold	190	–	–	﹤0.01%	421
2022 Q1	$25K	Sell	190 -125	-40%	-$16.3K	﹤0.01%	403
2021 Q4	$48K	Hold	315	–	–	﹤0.01%	383
2021 Q3	$51K	Hold	315	–	–	﹤0.01%	373
2021 Q2	$52K	Hold	315	–	–	﹤0.01%	373
2021 Q1	$47K	Sell	315 -95	-23%	-$15.1K	﹤0.01%	380
2020 Q4	$62K	Sell	410 -190	-32%	-$27.2K	0.01%	359
2020 Q3	$81K	Hold	600	–	–	0.01%	293
2020 Q2	$82K	Hold	600	–	–	0.01%	286
2020 Q1	$65K	Hold	600	–	–	0.01%	285
2019 Q4	$72K	Hold	600	–	–	0.01%	352
2019 Q3	$60K	Hold	600	–	–	﹤0.01%	404
2019 Q2	$65K	Buy	+600	New	+$63.8K	﹤0.01%	482

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

James Investment Research's IBB Position: Q2 2023 in Review

James Investment Research sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 190 shares — an estimated $25K sold.

James Investment Research first reported a position in IBB in Q2 2019 and held it in 16 quarters. The position peaked at $82K in Q2 2020. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

James Investment Research reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
James Investment Research sold 190 iShares Biotechnology ETF shares in Q2 2023, an estimated $25K.
James Investment Research first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 16 quarters.
James Investment Research's iShares Biotechnology ETF position peaked at $82K in Q2 2020.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.